Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
cysteine hydrochloride
DRUG
2 trials
Sponsors
FDA Office of Orphan Products Development
, Brigham and Women's Hospital
Conditions
Erythropoietic Protoporphyria
Phase 3
Phase III Study of L-Cysteine in Patients With Erythropoietic Protoporphyria
Completed
NCT00004940
Brigham and Women's Hospital
Erythropoietic Protoporphyria
Start: 1996-05-31
End: 2001-09-30
Target: 50
Updated: 2015-03-25
Unknown Phase
Study of Cysteine Hydrochloride for Erythropoietic Protoporphyria
Completed
NCT00004831
FDA Office of Orphan Products Development
Erythropoietic Protoporphyria
Start: 1996-10-31
End: 1998-07-31
Target: 20
Updated: 2015-03-25